As of April 16, 2025, Amneal Pharmaceuticals (AMRX) has a market cap of $3.34 billion USD. According to our data, Amneal Pharmaceuticals is ranked No.3195 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $3.34 B |
36.01%
|
Dec 31, 2024 | $2.45 B |
30.48%
|
Dec 29, 2023 | $1.88 B |
205.03%
|
Dec 30, 2022 | $0.62 B |
-58.46%
|
Dec 31, 2021 | $1.48 B |
4.81%
|
Dec 31, 2020 | $1.42 B |
-5.19%
|
Dec 31, 2019 | $1.49 B |
-64.38%
|
Dec 31, 2018 | $4.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() Viatris
VTRS
|
$8.93 B |
-0.000 M
|
![]() USA
|
![]() Perrigo
PRGO
|
$3.42 B |
-0.000 M
|
![]() Ireland
|
![]() Dr. Reddy's
RDY
|
$11.10 B |
0.000 M
|
![]() India
|
Market Cap | = | AMRX Stock Price | * | AMRX Shares Outstanding |
= | $7.17 | * | 0.31 B | |
= | $3.34 B |